The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic

J Clin Apher. 2021 Dec;36(6):878-881. doi: 10.1002/jca.21939. Epub 2021 Sep 12.

Abstract

Since vaccination for SARS-CoV-2 coronavirus started, the trajectory of patient numbers infected with the virus has improved once; however, variants of SARS-CoV-2 have emerged and more people have been infected; therefore, pandemic status is still far from resolution. Government and social efforts to prevent coronavirus infection continue in most states in the US and globally even after the Centers for Disease Control and Prevention declared some restriction relief for fully vaccinated people in March 2021. Healthcare institutions and various professional organizations have developed guidelines or policies to prevent the spread of these coronaviruses in the setting of apheresis. In this report, the issues that apheresis services may encounter under the current COVID-19 (SARS-CoV-2 coronavirus disease) pandemic will be discussed with potential strategies that can be adapted for efficient and optimum use of apheresis resources.

Keywords: ASFA COVID-19 Taskforce; SARS-CoV-2; apheresis in COVID-19 pandemic.

Publication types

  • Review

MeSH terms

  • Blood Component Removal* / methods
  • Blood Component Removal* / statistics & numerical data
  • COVID-19 / epidemiology*
  • Humans
  • Pandemics*
  • Practice Guidelines as Topic
  • SARS-CoV-2
  • Societies, Medical
  • United States / epidemiology